Clinical profile and management of PDA in neonates

Indian Journal of Pediatrics

Volumn 64, Issue 5, 1997, Pages 667-670

  Shanthala, C C ^a   Maiya, P P ^a   Vishwanath, D ^a   Banakappa, Naveen ^a   Mallikarjuna Swamy, P ^a   Desai, Nagaraj ^a   Ravikishore, ^a   Srinivas, K H ^a  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

Doppler echocardiography; Indomethacin; Patent ductus arteriosus

Indexed keywords

INDOMETACIN;

ARTICLE; CLINICAL ARTICLE; DOPPLER ECHOCARDIOGRAPHY; HUMAN; NEWBORN; NEWBORN DISEASE; ORAL DRUG ADMINISTRATION; PATENT DUCTUS ARTERIOSUS; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL RATE; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030846174     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02726122     Document Type: Article

References (14)

1. Tsu F. Yeh and Ian Carr. Pharmacologic Closure of Patent Ductus Arteriosus in Drug Therapy in the Neonatal and Small Infant Year Book Medical Publishers, 1985 : 116-130.
2. Siass, B et al. Incidence and clinical features of patent ductus arteriosus in low birth weight infants, a prospective analysis of 150 consecutively born infants. Pediatrics 1976; 57 : 347-351.
3. Yeh TF et al. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus : a double blind controlled study. J Pediatr 1981 a; 98: 136-145.
4. Heymann MA, Rudolph AM, Silvermann NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295 : 530-533.
5. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979; 95 : 865-866.
6. Friedman WF, Hirschklan MJ, Printz MP et al. Pharmacological closure of patent ductus arteriosus in the premature infants. N Engl J Med 1976; 295 : 526-529.
7. A. Shenoi, A. Narang, O.N. Bhakoo, P.S. Bidwai. Clinical profile and management of symtomatic patent ductus arteriosus in premature infants. Indian Pediatrics 1991; 28 : 125-130.
8. Nick Archer. Patent Ductus Arteriosus in the Newborn. Arch Dis Child 1993; 69 : 529-532.
9. Ellison RC, Peckham GL, Lang P et al. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 1983; 71 : 364-372.
10. Cotton RB, Stahlman MT, Kovar I, Catterton W2. Medical management of small preterm infants with symptomatic patient ductus arteriosus. J Pediatr 1978; 92 : 467-474.
11. Blanco EC, Siasi B and Cabal LA. Persistent patency of ductus arteriosus in premature newborn infants. Am J cardiol (abst) 1973; 31 : 120.
12. Gentile R, Stevenson G, Dooley T, Franklin D, Kawabori I, Pearlman A. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr 1981; 98 : 443-448.
13. Friedman Z, Demers LM, Marks KH, Uhrmann S, Maisels MJ. Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low birth weight infants. J Pediatr 1978; 93 : 512-515.
14. Gersony WH, Peckham GH, Ellison RC et al. Effect of indomethacin in premature infants with Patent-ductus arteriosus, Results of National Collaborative study. J Pediatr 1983; 102 : 895.